Accelerated Approval for RECCE® 327, page-77

Finally some realistic comments. The (self serving) talking up of the any day now spectacular rise of the value of this company is sometimes a bit annoying. The amount of cash needed to get through the clinical trial stages before you can hope for approval is huge and we're years away from that. Long term this may be good, but as all (medical) biotech a gamble. Doesn't stop me from investing but I expect to lose it all although hope for a good return. In my mind (and experience) at this stage this is high speculative stock, a gamble.